Models could help predict AML risk

In a Nature paper, a team led by researchers at University Health Network and Wellcome Sanger Institute developed two models to predict healthy subjects’ likelihood for developing acute myelogenous leukemia that could provide the basis for an AML risk diagnostic.

The first method was based on recurrent mutations in genes associated with AML that accumulate in clonally expanding hematopoietic stem and progenitor cells...